We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$295M
AUM Growth
+$6.53M
Cap. Flow
+$463K
Cap. Flow %
0.16%
Top 10 Hldgs %
36.21%
Holding
139
New
4
Increased
58
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$1.18M
2
WM icon
Waste Management
WM
+$507K
3
IDCC icon
InterDigital
IDCC
+$308K
4
CVX icon
Chevron
CVX
+$217K
5
CFR icon
Cullen/Frost Bankers
CFR
+$189K

Top Sells

Rank Stock Value
1
FLR icon
Fluor
FLR
+$1.38M
2
SO icon
Southern Company
SO
+$429K
3
CSX icon
CSX Corp
CSX
+$326K
4
MSFT icon
Microsoft
MSFT
+$223K
5
ACH
Accendra Health
ACH
+$208K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Financials 14.84%
3 Healthcare 13.22%
4 Consumer Staples 13.03%
5 Consumer Discretionary 11.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$322B
$3.99M 1.35%
49,161
-317
-0.6% -$25.4K
UPS icon
27
United Parcel Service
UPS
$88.6B
$3.91M 1.32%
32,613
+1,503
+5% +$172K
KMB icon
28
Kimberly-Clark
KMB
$36.3B
$3.73M 1.27%
26,216
+229
+0.9% +$31.5K
AMGN icon
29
Amgen
AMGN
$208B
$3.69M 1.25%
19,048
+462
+2% +$88.7K
SON icon
30
Sonoco
SON
$5.57B
$3.53M 1.2%
60,586
+140
+0.2% +$8.34K
XRAY icon
31
Dentsply Sirona
XRAY
$2.68B
$3.36M 1.14%
62,942
-118
-0.2% -$6.34K
TECH icon
32
Bio-Techne
TECH
$11.2B
$3.33M 1.13%
67,208
-200
-0.3% -$10K
TFX icon
33
Teleflex
TFX
$6.05B
$3.27M 1.11%
9,586
-15
-0.2% -$5.23K
CPRT icon
34
Copart
CPRT
$27B
$3.19M 1.08%
158,920
-4,884
-3% -$94.8K
CSX icon
35
CSX Corp
CSX
$93.4B
$2.85M 0.97%
122,859
-13,995
-10% -$326K
COP icon
36
ConocoPhillips
COP
$147B
$2.8M 0.95%
49,425
-3,422
-6% -$195K
CMP icon
37
Compass Minerals
CMP
$1.23B
$2.67M 0.91%
47,021
+1,276
+3% +$68.4K
DIS icon
38
Walt Disney
DIS
$167B
$2.56M 0.87%
19,615
+8,515
+77% +$1.18M
AFL icon
39
Aflac
AFL
$64.9B
$2.55M 0.87%
48,653
+528
+1% +$27.9K
PAYX icon
40
Paychex
PAYX
$41.6B
$2.47M 0.84%
29,890
+647
+2% +$53.8K
DUK icon
41
Duke Energy
DUK
$97.8B
$2.38M 0.81%
24,903
+475
+2% +$43.2K
PFE icon
42
Pfizer
PFE
$143B
$2.22M 0.75%
64,719
+1,555
+2% +$56.5K
GOOG icon
43
Alphabet (Google) Class C
GOOG
$4.36T
$2.18M 0.74%
35,780
+1,960
+6% +$116K
MMS icon
44
Maximus
MMS
$3.17B
$2.14M 0.73%
27,800
+1,040
+4% +$79K
PDCO
45
DELISTED
Patterson Companies, Inc.
PDCO
$1.96M 0.66%
109,362
+5,143
+5% +$96K
COST icon
46
Costco
COST
$422B
$1.91M 0.65%
6,633
+20
+0.3% +$5.63K
WU icon
47
Western Union
WU
$1.98B
$1.89M 0.64%
81,227
+830
+1% +$17.9K
GL icon
48
Globe Life
GL
$14.2B
$1.7M 0.58%
17,683
-225
-1% -$20.4K
CTAS icon
49
Cintas
CTAS
$81.9B
$1.66M 0.56%
24,712
-320
-1% -$20.5K
GILD icon
50
Gilead Sciences
GILD
$162B
$1.61M 0.55%
25,334
+2,610
+11% +$171K

Similar funds

Rowlandmiller & Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Rowlandmiller & Partners held 139 positions worth $295M, up 2.3% from $288M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Rowlandmiller & Partners's Q3 2019 filing shows 4 new, 58 increased, 41 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 3,055 shares worth $156K. The largest sale was Fluor, an estimated $1.38M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Rowlandmiller & Partners's largest Q3 2019 buy was Bristol-Myers Squibb: 3,055 shares worth $156K.
  • Rowlandmiller & Partners added most to Walt Disney in Q3 2019, an estimated $1.18M increase.
  • Rowlandmiller & Partners's biggest Q3 2019 reduction was Southern Company, cutting an estimated $429K.
  • Rowlandmiller & Partners fully exited Fluor in Q3 2019, selling an estimated $1.38M.
  • Rowlandmiller & Partners's ten largest holdings make up 36% of its $295M portfolio in Q3 2019.
  • Rowlandmiller & Partners opened 4 new positions and closed 3 in Q3 2019.
  • Rowlandmiller & Partners's portfolio value rose 2.3% quarter-over-quarter to $295M.

Based on Rowlandmiller & Partners's 13F filing for Q3 2019, filed 2 Oct 2019.